ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,69
0,14%
Dow Jones
43 343,98
0,11%
DAX
19 848,77
-0,34%
Brent Oil
72,94
-0,47%
Bitcoin
95 732,78
-3,59%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. CG Oncology Inc (CGON) Cours

CG Oncology Inc

CG Oncology Inc (CGON)

NASDAQ
29,00
0,70
( 2,47% )
Mis à jour : 19:09:11
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
29,00
Prix Achat
29,00
Prix Vente
29,07
Volume échangé
154 318
27,82 Fourchette du Jour 29,25
25,77 Plage de 52 semaines 50,23
Cap du marché
1,961B
Clôture Veille
28,30
Ouverture
28,06
Dernière Transaction
2
@
29.0402
Dernière heure de transaction
19:10:10
Volume financier
US$ 4 415 863
VWAP
28,6153
Volume moyen (3 m)
594 151
Actions en circulation
67 629 675
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-28,91
Bénéfice par action (BPA)
-1
Chiffre d'affairess
204k
Bénéfice net
-67,8M

À propos de CG Oncology Inc

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live ... CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
cgoncology.com
Siège social
Dover, Delaware, USA
Fondé
-
CG Oncology Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker CGON. Le dernier cours de clôture d'CG Oncology était de US$28,30. Au cours de la dernière année, les actions de CG Oncology ont été négociées dans une fourchette de prix de US$ 25,77 à US$ 50,23.

CG Oncology compte actuellement 67 629 675 actions en circulation. La capitalisation boursière d'CG Oncology est de US$1,91 milliard. CG Oncology a un ratio cours/bénéfice (ratio PE) de -28.91.

CGON Dernières nouvelles

Plus de nouvelles

Form 4 - Statement of changes in beneficial ownership of securities

18 Décembre 2024
Edgar (US Regulatory)

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

16 Décembre 2024
GlobeNewswire Inc.

Form 424B4 - Prospectus [Rule 424(b)(4)]

13 Décembre 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

13 Décembre 2024
Edgar (US Regulatory)

CG Oncology Announces Pricing of Public Offering

IRVINE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

13 Décembre 2024
GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

11 Décembre 2024
Edgar (US Regulatory)

CG Oncology Announces Proposed Public Offering

IRVINE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

11 Décembre 2024
GlobeNewswire Inc.

SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and...

06 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

05 Décembre 2024
Edgar (US Regulatory)

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

– 74.5% of patients achieved a complete response at any time – – Median duration of response is greater than 27 months and not reached – – Latest data update continued to show favorable safety...

05 Décembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.381.3277428371828.6229.252792066028.31373991CS
4-5.24-15.303738317834.2436.732798206030.49378781CS
12-7.14-19.756502490336.1440.472759415133.02580161CS
26-2.14-6.8721901091831.1440.472765659634.67243524CS
52002950.2325.7767789335.56027599CS
156002950.2325.7767789335.56027599CS
260002950.2325.7767789335.56027599CS

CGON - Frequently Asked Questions (FAQ)

What is the current CG Oncology share price?
The current share price of CG Oncology is US$ 29,00
How many CG Oncology shares are in issue?
CG Oncology has 67 629 675 shares in issue
What is the market cap of CG Oncology?
The market capitalisation of CG Oncology is USD 1,91B
What is the 1 year trading range for CG Oncology share price?
CG Oncology has traded in the range of US$ 25,77 to US$ 50,23 during the past year
What is the PE ratio of CG Oncology?
The price to earnings ratio of CG Oncology is -28,91
What is the cash to sales ratio of CG Oncology?
The cash to sales ratio of CG Oncology is 9,66k
What is the reporting currency for CG Oncology?
CG Oncology reports financial results in USD
What is the latest annual turnover for CG Oncology?
The latest annual turnover of CG Oncology is USD 204k
What is the latest annual profit for CG Oncology?
The latest annual profit of CG Oncology is USD -67,8M
What is the registered address of CG Oncology?
The registered address for CG Oncology is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901
What is the CG Oncology website address?
The website address for CG Oncology is cgoncology.com
Which industry sector does CG Oncology operate in?
CG Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
AIREreAlpha Tech Corporation
US$ 3,52
(156,93%)
100,79M
MGIHMillennium Group International Holdings Ltd
US$ 3,49
(128,10%)
71,74M
SPRCSciSparc Ltd
US$ 0,4759
(115,14%)
209,35M
BCGBinah Capital Group Inc
US$ 4,21
(112,63%)
6,87M
SKKSKK Holdings Limited
US$ 1,56
(108,56%)
45,06M
LNKSLinkers Industries Ltd
US$ 3,47
(-63,82%)
1,3M
BAOSBaosheng Media Group Holdings Ltd
US$ 4,10
(-42,25%)
1,44M
GTIGraphjet Technology
US$ 0,41
(-32,79%)
14,71M
SVRESaverOne 2014 Ltd
US$ 1,02
(-32,45%)
996,06k
NEUPNeuphoria Therapeutics Inc
US$ 4,79
(-27,75%)
486,83k
SPRCSciSparc Ltd
US$ 0,4818
(117,81%)
209,35M
COEPCoeptis Therapeutics Holdings Inc
US$ 0,208
(46,48%)
191,32M
XTIAXTI Aerospace Inc
US$ 0,0407
(3,83%)
191,23M
RGTIRigetti Computing Inc
US$ 14,60
(28,63%)
151,96M
SMXSMX Security Matters Public Company
US$ 0,3746
(71,83%)
149,41M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
CGON
CG Oncology
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés